Icotrokinra vs PT-141
Overview
Icotrokinra is primarily a immune support peptide, while PT-141 is used for hormonal.
This page compares Icotrokinra and PT-141 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Icotrokinra | PT-141 | |
|---|---|---|
| Category | Immune Support | Hormonal |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | — | 1.75 mg |
| Frequency | — | as needed |
| Reported benefits | — | Enhanced libido, improved sexual function, arousal support |
| Reported side effects | — | Nausea, flushing, blood pressure changes |
Key differences
Primary use. Icotrokinra is categorised under Immune Support, while PT-141 falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Icotrokinra: FDA-approved. PT-141: FDA-approved.
Dosing. Typical dosing for Icotrokinra is not catalogued. PT-141 is typically dosed at 1.75 mg (as needed).
Can you stack them?
Some protocols combine peptides, but stacking Icotrokinra and PT-141 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Icotrokinra and PT-141?
- Icotrokinra is primarily a immune support peptide, while PT-141 is used for hormonal. Icotrokinra is FDA-approved for one or more indications, whereas PT-141 is FDA-approved for one or more indications.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- What is PT-141 used for?
- Sexual function peptide.
- Can you take Icotrokinra and PT-141 together?
- Some users combine peptides within a single protocol, but stacking Icotrokinra and PT-141 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Icotrokinra or PT-141 FDA-approved?
- Icotrokinra is FDA-approved for one or more indications. PT-141 is FDA-approved for one or more indications.
Read the full articles
- Icotrokinra — full monograph: mechanism, research, dosing & references
- PT-141 — full monograph: mechanism, research, dosing & references